Taigo Kato Selected Research

Taigo Kato Research Topics

Disease

39	Neoplasms (Cancer) 12/2022 - 02/2008
14	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 02/2008
13	Carcinoma (Carcinomatosis) 12/2022 - 07/2006
6	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2018
5	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2015
4	Disease Progression 12/2022 - 01/2016
4	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 01/2020
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 10/2009
4	Inflammation (Inflammations) 01/2021 - 06/2014
3	Ovarian Neoplasms (Ovarian Cancer) 11/2018 - 12/2016
2	Neoplasm Metastasis (Metastasis) 05/2022 - 04/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2021
2	Renal Insufficiency (Renal Failure) 01/2022 - 12/2020
2	Proteinuria 01/2020 - 06/2019
2	Hematuria 01/2020 - 07/2006
2	Glomerulonephritis 01/2020 - 01/2019
2	IGA Glomerulonephritis (IGA Nephropathy) 06/2019 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2018
2	Hemorrhage 03/2018 - 08/2008
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2017 - 03/2016
1	Patent Ductus Arteriosus 03/2022
1	Wounds and Injuries (Trauma) 03/2022
1	Circulating Neoplastic Cells 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Dysbiosis 01/2022
1	Melanoma (Melanoma, Malignant) 05/2021
1	COVID-19 01/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2016
8	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2018
7	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2018
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2017
6	Cell-Free Nucleic AcidsIBA 05/2022 - 04/2018
5	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 02/2019
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
3	NivolumabIBA 10/2022 - 05/2021
3	Circulating Tumor DNAIBA 05/2022 - 02/2019
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 01/2020
3	AntigensIBA 01/2022 - 09/2017
3	Small Interfering RNA (siRNA)IBA 08/2017 - 01/2016
3	OTS167IBA 08/2017 - 03/2016
3	Protein Kinases (Protein Kinase)IBA 03/2017 - 04/2016
2	pembrolizumabIBA 12/2022 - 10/2021
2	IpilimumabIBA 10/2022 - 01/2022
2	EnzymesIBA 10/2022 - 07/2011
2	Biological ProductsIBA 04/2022 - 07/2018
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 07/2020
2	MicroRNAs (MicroRNA)IBA 04/2021 - 04/2020
2	Methylprednisolone FDA LinkGeneric 01/2021 - 01/2020
2	HydrogenIBA 12/2020 - 01/2020
2	Immunoglobulin A (IgA)IBA 06/2019 - 01/2019
2	Pharmaceutical PreparationsIBA 07/2018 - 01/2016
2	OTS514IBA 12/2016 - 04/2016
2	Phosphotransferases (Kinase)IBA 04/2016 - 03/2016
2	DesminIBA 12/2010 - 10/2009
1	ImmunosorbentsIBA 10/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2022
1	EphrinsIBA 10/2022
1	GelatinIBA 03/2022
1	Calcineurin InhibitorsIBA 01/2022
1	Everolimus FDA Link 01/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022
1	SteroidsIBA 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	sacituzumab govitecanIBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2022
1	Histamine H1 AntagonistsIBA 01/2022
1	LigandsIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Capsules (Microcapsules)IBA 01/2022
1	fexofenadine (Allegra)FDA LinkGeneric 01/2022
1	Tyrosine Kinase InhibitorsIBA 11/2021
1	AlbuminsIBA 10/2021
1	BilirubinIBA 10/2021
1	Carboplatin (JM8)FDA LinkGeneric 07/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	lardIBA 01/2021
1	Granzymes (Granzyme)IBA 01/2021
1	PerforinIBA 01/2021

Therapy/Procedure

17	Therapeutics 12/2022 - 02/2008
11	Kidney Transplantation 01/2022 - 07/2009
7	Transplantation 01/2022 - 07/2009
6	Nephrectomy 10/2022 - 02/2008
5	Immunotherapy 12/2022 - 07/2018
4	Drug Therapy (Chemotherapy) 05/2022 - 07/2010
2	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 01/2018
2	Cryosurgery 05/2021 - 01/2017
2	Aftercare (After-Treatment) 01/2021 - 01/2017
2	Oral Administration 01/2021 - 01/2020
2	Castration 12/2020 - 05/2020
2	Cystectomy 08/2009 - 07/2006
2	Nephroureterectomy 08/2009 - 02/2009
1	Intravesical Administration 04/2022
1	Urinary Catheters 03/2022